Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FKAQ5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,203
Award facts
- Contract value 100% obligated
- $13,203.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 200-unit vials of BOTOX totaling $13,203.20 under a firm fixed-price contract structure. This delivery order, awarded on December 16, 2025, with an ultimate completion date of January 8, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense pharmaceutical supply chain, maintaining a substantial portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals since its registration in the System for Award Management in 2001. The company's PPV-G GEN V prime vendor contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This delivery order for BOTOX reflects the ongoing medical supply requirements of military healthcare operations and demonstrates DMS Pharmaceutical Group's role as a regional pharmaceutical prime vendor serving Department of Defense facilities globally.
Quick answers
Who was awarded contract SPE2DR26FKAQ5?
SPE2DR26FKAQ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FKAQ5 worth?
The government has obligated $13,203 on SPE2DR26FKAQ5.
Is contract SPE2DR26FKAQ5 an order under another contract?
Yes. SPE2DR26FKAQ5 is a delivery order under SPE2DR25D9365, an indefinite delivery contract.
Was contract SPE2DR26FKAQ5 competed?
The extent of competition for SPE2DR26FKAQ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award